Skip to main content
Top
Published in: The International Journal of Cardiovascular Imaging 2/2012

01-12-2012

Effects of hypertrophy and fibrosis on regional and global functional heterogeneity in hypertrophic cardiomyopathy

Authors: Sung-A Chang, Sang-Chol Lee, Yeon Hyeon Choe, Hye-Jin Hahn, Shin Yi Jang, Sung-Ji Park, Jin-Oh Choi, Seung Woo Park, Jae K. Oh

Published in: The International Journal of Cardiovascular Imaging | Special Issue 2/2012

Login to get access

Abstract

Hypertrophic cardiomyopathy (HCM) is a disease that typically has heterogeneous hypertrophy and dysfunction of the myocardium. Cardiac magnetic resonance imaging (CMR) can be used to accurately assess ventricular wall thickness and regional fibrosis. We investigated the effects of hypertrophy and fibrosis on the heterogeneity of regional and global myocardial function in HCM. Forty patients who were diagnosed with HCM were consecutively enrolled. Echocardiography and CMR with delayed hyper-enhancement imaging (DHE) was performed for each patient. Left ventricular (LV) regional and global longitudinal strain (SLR and SLG) were obtained by two-dimensional speckle tracking method on echocardiography. With CMR, regional myocardial wall thickness was measured, and the amount of DHE was calculated semi-quantitatively in each segment. Overall, 720 segments were analyzed. SLR was significantly decreased in the hypertrophied segments (thickness > 11 mm) and segments with DHE (P < 0.001). SLR was correlated with myocardial wall thickness (r = 0.47, P = 0.001) and amount of regional DHE (r = 0.39, P < 0.001). On multivariate analysis, regional LV wall thickness and amount of DHE were the only independent determinants of SLR. SLG was associated with LV diastolic functional parameters in echocardiography, total DHE volume, and LV mass index. Total DHE volume and LV mass index were independent determinants of SLG on multivariate analysis. The extent of regional myocardial fibrosis is associated with regional myocardial function independently of morphological changes of the myocardium, and the correlation extended to global LV function. In this context, DHE may be a useful parameter to discover early myocardial dysfunction independently of LV hypertrophy.
Literature
1.
go back to reference Maron BJ, Bonow RO, Cannon RO III, Leon MB, Epstein SE (1987) Hypertrophic cardiomyopathy: interrelations of clinical manifestations, pathophysiology, and therapy (1). N Engl J Med 316(13):780–789PubMedCrossRef Maron BJ, Bonow RO, Cannon RO III, Leon MB, Epstein SE (1987) Hypertrophic cardiomyopathy: interrelations of clinical manifestations, pathophysiology, and therapy (1). N Engl J Med 316(13):780–789PubMedCrossRef
2.
go back to reference Maron BJ, Gottdiener JS, Epstein SE (1981) Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a wide angle, two dimensional echocardiographic study of 125 patients. Am J Cardiol 48(3):418–428PubMedCrossRef Maron BJ, Gottdiener JS, Epstein SE (1981) Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a wide angle, two dimensional echocardiographic study of 125 patients. Am J Cardiol 48(3):418–428PubMedCrossRef
3.
go back to reference Eriksson MJ, Sonnenberg B, Woo A, Rakowski P, Parker TG, Wigle ED, Rakowski H (2002) Long-term outcome in patients with apical hypertrophic cardiomyopathy. J Am Coll Cardiol 39(4):638–645PubMedCrossRef Eriksson MJ, Sonnenberg B, Woo A, Rakowski P, Parker TG, Wigle ED, Rakowski H (2002) Long-term outcome in patients with apical hypertrophic cardiomyopathy. J Am Coll Cardiol 39(4):638–645PubMedCrossRef
4.
go back to reference Dimitrow PP, Klimeczek P, Vliegenthart R, Pasowicz M, Oudkerk M, Podolec P, Tracz W, Dubiel JS (2008) Late hyperenhancement in gadolinium-enhanced magnetic resonance imaging: comparison of hypertrophic cardiomyopathy patients with and without nonsustained ventricular tachycardia. Int J Cardiovasc Imaging 24(1):77–83, discussion 85–77. 10.1007/s10554-007-9209-9 Dimitrow PP, Klimeczek P, Vliegenthart R, Pasowicz M, Oudkerk M, Podolec P, Tracz W, Dubiel JS (2008) Late hyperenhancement in gadolinium-enhanced magnetic resonance imaging: comparison of hypertrophic cardiomyopathy patients with and without nonsustained ventricular tachycardia. Int J Cardiovasc Imaging 24(1):77–83, discussion 85–77. 10.​1007/​s10554-007-9209-9
5.
go back to reference Aquaro GD, Masci P, Formisano F, Barison A, Strata E, Pingitore A, Positano V, Spirito P, Lombardi M (2010) Usefulness of delayed enhancement by magnetic resonance imaging in hypertrophic cardiomyopathy as a marker of disease and its severity. Am J Cardiol 105(3):392–397. doi:10.1016/j.amjcard.2009.09.045 PubMedCrossRef Aquaro GD, Masci P, Formisano F, Barison A, Strata E, Pingitore A, Positano V, Spirito P, Lombardi M (2010) Usefulness of delayed enhancement by magnetic resonance imaging in hypertrophic cardiomyopathy as a marker of disease and its severity. Am J Cardiol 105(3):392–397. doi:10.​1016/​j.​amjcard.​2009.​09.​045 PubMedCrossRef
6.
go back to reference Bruder O, Wagner A, Jensen CJ, Schneider S, Ong P, Kispert EM, Nassenstein K, Schlosser T, Sabin GV, Sechtem U, Mahrholdt H (2010) Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 56(11):875–887. doi:10.1016/j.jacc.2010.05.007 PubMedCrossRef Bruder O, Wagner A, Jensen CJ, Schneider S, Ong P, Kispert EM, Nassenstein K, Schlosser T, Sabin GV, Sechtem U, Mahrholdt H (2010) Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 56(11):875–887. doi:10.​1016/​j.​jacc.​2010.​05.​007 PubMedCrossRef
7.
go back to reference Chang SA, Kim HK, Kim DH, Kim JC, Kim YJ, Kim HC, Sohn DW, Oh BH, Park YB (2010) Left ventricular twist mechanics in patients with apical hypertrophic cardiomyopathy: assessment with 2D speckle tracking echocardiography. Heart 96(1):49–55. doi:10.1136/hrt.2009.166629 PubMedCrossRef Chang SA, Kim HK, Kim DH, Kim JC, Kim YJ, Kim HC, Sohn DW, Oh BH, Park YB (2010) Left ventricular twist mechanics in patients with apical hypertrophic cardiomyopathy: assessment with 2D speckle tracking echocardiography. Heart 96(1):49–55. doi:10.​1136/​hrt.​2009.​166629 PubMedCrossRef
8.
go back to reference Hung CL, Verma A, Uno H, Shin SH, Bourgoun M, Hassanein AH, McMurray JJ, Velazquez EJ, Kober L, Pfeffer MA (2010) Longitudinal and circumferential strain rate, left ventricular remodeling, and prognosis after myocardial infarction. J Am College of Cardiology 56(22):1812–1822CrossRef Hung CL, Verma A, Uno H, Shin SH, Bourgoun M, Hassanein AH, McMurray JJ, Velazquez EJ, Kober L, Pfeffer MA (2010) Longitudinal and circumferential strain rate, left ventricular remodeling, and prognosis after myocardial infarction. J Am College of Cardiology 56(22):1812–1822CrossRef
9.
go back to reference Janik M, Cham MD, Ross MI, Wang Y, Codella N, Min JK, Prince MR, Manoushagian S, Okin PM, Devereux RB, Weinsaft JW (2008) Effects of papillary muscles and trabeculae on left ventricular quantification: increased impact of methodological variability in patients with left ventricular hypertrophy. J Hypertens 26(8):1677–1685. doi:10.1097/HJH.0b013e328302ca14 PubMedCrossRef Janik M, Cham MD, Ross MI, Wang Y, Codella N, Min JK, Prince MR, Manoushagian S, Okin PM, Devereux RB, Weinsaft JW (2008) Effects of papillary muscles and trabeculae on left ventricular quantification: increased impact of methodological variability in patients with left ventricular hypertrophy. J Hypertens 26(8):1677–1685. doi:10.​1097/​HJH.​0b013e328302ca14​ PubMedCrossRef
11.
go back to reference Song YB, Hahn JY, Gwon HC, Kim JH, Lee SY, Choe YH, Choi SH, Choi JH, Lee SH (2009) Upstream high-dose tirofiban does not reduce myocardial infarct size in patients undergoing primary percutaneous coronary intervention: a magnetic resonance imaging pilot study. Clin Cardiol 32(6):321–326. doi:10.1002/clc.20551 PubMedCrossRef Song YB, Hahn JY, Gwon HC, Kim JH, Lee SY, Choe YH, Choi SH, Choi JH, Lee SH (2009) Upstream high-dose tirofiban does not reduce myocardial infarct size in patients undergoing primary percutaneous coronary intervention: a magnetic resonance imaging pilot study. Clin Cardiol 32(6):321–326. doi:10.​1002/​clc.​20551 PubMedCrossRef
12.
go back to reference Gutman J, Wang YS, Wahr D, Schiller NB (1983) Normal left atrial function determined by 2-dimensional echocardiography. Am J Cardiol 51(2):336–340PubMedCrossRef Gutman J, Wang YS, Wahr D, Schiller NB (1983) Normal left atrial function determined by 2-dimensional echocardiography. Am J Cardiol 51(2):336–340PubMedCrossRef
13.
go back to reference Popovic ZB, Kwon DH, Mishra M, Buakhamsri A, Greenberg NL, Thamilarasan M, Flamm SD, Thomas JD, Lever HM, Desai MY (2008) Association between regional ventricular function and myocardial fibrosis in hypertrophic cardiomyopathy assessed by speckle tracking echocardiography and delayed hyperenhancement magnetic resonance imaging. J Am Soc Echocardiogr 21(12):1299–1305PubMedCrossRef Popovic ZB, Kwon DH, Mishra M, Buakhamsri A, Greenberg NL, Thamilarasan M, Flamm SD, Thomas JD, Lever HM, Desai MY (2008) Association between regional ventricular function and myocardial fibrosis in hypertrophic cardiomyopathy assessed by speckle tracking echocardiography and delayed hyperenhancement magnetic resonance imaging. J Am Soc Echocardiogr 21(12):1299–1305PubMedCrossRef
14.
go back to reference Melacini P, Basso C, Angelini A, Calore C, Bobbo F, Tokajuk B, Bellini N, Smaniotto G, Zucchetto M, Iliceto S, Thiene G, Maron BJ (2010) Clinicopathological profiles of progressive heart failure in hypertrophic cardiomyopathy. Eur Heart J 31(17):2111–2123. doi:10.1093/eurheartj/ehq136 PubMedCrossRef Melacini P, Basso C, Angelini A, Calore C, Bobbo F, Tokajuk B, Bellini N, Smaniotto G, Zucchetto M, Iliceto S, Thiene G, Maron BJ (2010) Clinicopathological profiles of progressive heart failure in hypertrophic cardiomyopathy. Eur Heart J 31(17):2111–2123. doi:10.​1093/​eurheartj/​ehq136 PubMedCrossRef
15.
go back to reference Nihoyannopoulos P, Karatasakis G, Frenneaux M, McKenna WJ, Oakley CM (1992) Diastolic function in hypertrophic cardiomyopathy: relation to exercise capacity. J Am Coll Cardiol 19(3):536–540PubMedCrossRef Nihoyannopoulos P, Karatasakis G, Frenneaux M, McKenna WJ, Oakley CM (1992) Diastolic function in hypertrophic cardiomyopathy: relation to exercise capacity. J Am Coll Cardiol 19(3):536–540PubMedCrossRef
16.
go back to reference Spirito P, Maron BJ (1990) Relation between extent of left ventricular hypertrophy and diastolic filling abnormalities in hypertrophic cardiomyopathy. J Am Coll Cardiol 15(4):808–813PubMedCrossRef Spirito P, Maron BJ (1990) Relation between extent of left ventricular hypertrophy and diastolic filling abnormalities in hypertrophic cardiomyopathy. J Am Coll Cardiol 15(4):808–813PubMedCrossRef
18.
go back to reference Carasso S, Yang H, Woo A, Vannan MA, Jamorski M, Wigle ED, Rakowski H (2008) Systolic myocardial mechanics in hypertrophic cardiomyopathy: novel concepts and implications for clinical status. J Am Soc Echocardiogr 21(6):675–683PubMedCrossRef Carasso S, Yang H, Woo A, Vannan MA, Jamorski M, Wigle ED, Rakowski H (2008) Systolic myocardial mechanics in hypertrophic cardiomyopathy: novel concepts and implications for clinical status. J Am Soc Echocardiogr 21(6):675–683PubMedCrossRef
19.
go back to reference Pirat B, Khoury DS, Hartley CJ, Tiller L, Rao L, Schulz DG, Nagueh SF, Zoghbi WA (2008) A novel feature-tracking echocardiographic method for the quantitation of regional myocardial function: validation in an animal model of ischemia-reperfusion. J Am Coll Cardiol 51(6):651–659. doi:10.1016/j.jacc.2007.10.029 PubMedCrossRef Pirat B, Khoury DS, Hartley CJ, Tiller L, Rao L, Schulz DG, Nagueh SF, Zoghbi WA (2008) A novel feature-tracking echocardiographic method for the quantitation of regional myocardial function: validation in an animal model of ischemia-reperfusion. J Am Coll Cardiol 51(6):651–659. doi:10.​1016/​j.​jacc.​2007.​10.​029 PubMedCrossRef
20.
go back to reference Abozguia K, Nallur-Shivu G, Phan TT, Ahmed I, Kalra R, Weaver RA, McKenna WJ, Sanderson JE, Elliott P, Frenneaux MP (2010) Left ventricular strain and untwist in hypertrophic cardiomyopathy: relation to exercise capacity. Am Heart J 159(5):825–832. doi:10.1016/j.ahj.2010.02.002 PubMedCrossRef Abozguia K, Nallur-Shivu G, Phan TT, Ahmed I, Kalra R, Weaver RA, McKenna WJ, Sanderson JE, Elliott P, Frenneaux MP (2010) Left ventricular strain and untwist in hypertrophic cardiomyopathy: relation to exercise capacity. Am Heart J 159(5):825–832. doi:10.​1016/​j.​ahj.​2010.​02.​002 PubMedCrossRef
21.
go back to reference Lafitte S, Perlant M, Reant P, Serri K, Douard H, DeMaria A, Roudaut R (2009) Impact of impaired myocardial deformations on exercise tolerance and prognosis in patients with asymptomatic aortic stenosis. Eur J Echocardiogr 10(3):414–419. doi:10.1093/ejechocard/jen299 PubMedCrossRef Lafitte S, Perlant M, Reant P, Serri K, Douard H, DeMaria A, Roudaut R (2009) Impact of impaired myocardial deformations on exercise tolerance and prognosis in patients with asymptomatic aortic stenosis. Eur J Echocardiogr 10(3):414–419. doi:10.​1093/​ejechocard/​jen299 PubMedCrossRef
Metadata
Title
Effects of hypertrophy and fibrosis on regional and global functional heterogeneity in hypertrophic cardiomyopathy
Authors
Sung-A Chang
Sang-Chol Lee
Yeon Hyeon Choe
Hye-Jin Hahn
Shin Yi Jang
Sung-Ji Park
Jin-Oh Choi
Seung Woo Park
Jae K. Oh
Publication date
01-12-2012
Publisher
Springer Netherlands
Published in
The International Journal of Cardiovascular Imaging / Issue Special Issue 2/2012
Print ISSN: 1569-5794
Electronic ISSN: 1875-8312
DOI
https://doi.org/10.1007/s10554-012-0141-2

Other articles of this Special Issue 2/2012

The International Journal of Cardiovascular Imaging 2/2012 Go to the issue